GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Block Sciences (Nanjing) Inc (SZSE:300725) » Definitions » 3-Year ROIIC %

Pharma Block Sciences (Nanjing) (SZSE:300725) 3-Year ROIIC % : 2.02% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Pharma Block Sciences (Nanjing) 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 2.02%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % or its related term are showing as below:

SZSE:300725's 3-Year ROIIC % is ranked better than
52% of 998 companies
in the Drug Manufacturers industry
Industry Median: 0.915 vs SZSE:300725: 2.02

Pharma Block Sciences (Nanjing) 3-Year ROIIC % Historical Data

The historical data trend for Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Block Sciences (Nanjing) 3-Year ROIIC % Chart

Pharma Block Sciences (Nanjing) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.90 30.44 9.03 6.31 2.02

Pharma Block Sciences (Nanjing) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.02 - - -

Competitive Comparison of Pharma Block Sciences (Nanjing)'s 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Block Sciences (Nanjing)'s 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % falls into.



Pharma Block Sciences (Nanjing) 3-Year ROIIC % Calculation

Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 263.9954375 (Dec. 2023) - 197.1965559 (Dec. 2020) )/( 4083.673 (Dec. 2023) - 780.9 (Dec. 2020) )
=66.7988816/3302.773
=2.02%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Pharma Block Sciences (Nanjing)  (SZSE:300725) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Pharma Block Sciences (Nanjing) 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Pharma Block Sciences (Nanjing)'s 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Block Sciences (Nanjing) Business Description

Traded in Other Exchanges
N/A
Address
10 Xuefu Road, Nanjing High-tech Industrial Development Zone, Jiangsu, Nanjing, 210032, CHN, 210032
Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.
Executives
Yang Min Min Directors, executives
Directors, executives
Chen La Mei Executives
Wu Xi Han Director
Executives
Directors, executives
Luo Fei Supervisors

Pharma Block Sciences (Nanjing) Headlines

No Headlines